Showing results (91-100 of 138) with videos related to

Sort By:
Pageof 14
Proceedings of the National Academy of Sciences of the United States of America|June 12, 2013
Multifaceted oncolytic virus therapy for glioblastoma in an immunocompetent cancer stem cell modelTooba A Cheema, Hiroaki Wakimoto, Peter E Fecci, et al.
Cancer Gene Therapy|September 16, 2025
Promoting the therapeutic potential of interleukin-7 (IL-7) by expression in viral vectorsMyla Hudson, Robert H Newman, Checo J Rorie, et al.
Journal of Neuro-Oncology|July 21, 2009
Directed evolution of adeno-associated virus for glioma cell transductionCasey A Maguire, Davide Gianni, Dimphna H Meijer, et al.
Journal of the National Cancer Institute|December 17, 2011
Oncolytic virus-mediated manipulation of DNA damage responses: synergy with chemotherapy in killing glioblastoma stem cellsRyuichi Kanai, Samuel D Rabkin, Stephen Yip, et al.
Journal of Virology|May 26, 2018
Restriction of Replication of Oncolytic Herpes Simplex Virus with a Deletion of γ34.5 in Glioblastoma Stem-Like CellsCole Peters, Max Paget, Kizito-Tshitoko Tshilenge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2006
Dominant-negative fibroblast growth factor receptor expression enhances antitumoral potency of oncolytic herpes simplex virus in neural tumorsTa-Chiang Liu, Tingguo Zhang, Hiroshi Fukuhara, et al.
Plos Pathogens|March 14, 2009
Definition of herpes simplex virus type 1 helper activities for adeno-associated virus early replication eventsNathalie Alazard-Dany, Armel Nicolas, Aurélie Ploquin, et al.
Virology|June 26, 2012
Factors influencing helper-independent adeno-associated virus replicationArmel Nicolas, Nelly Jolinon, Nathalie Alazard-Dany, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 22, 2022
Histone deacetylase inhibitors enhance oncolytic herpes simplex virus therapy for malignant meningiomaYoichiro Kawamura, Lingyang Hua, Alessandra Gurtner, et al.
Pageof 14